Ad is loading...
PRMSX
Price
$34.53
Change
-$0.10 (-0.29%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

PRMSX vs RNWFX

Header iconPRMSX vs RNWFX Comparison
Open Charts PRMSX vs RNWFXBanner chart's image
T. Rowe Price Emerging Markets Stock
Price$34.53
Change-$0.10 (-0.29%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
PRMSX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRMSX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRMSX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. PRMSX (5.02B). RNWFX pays higher dividends than PRMSX: RNWFX (1.51) vs PRMSX (1.09). PRMSX was incepted earlier than RNWFX: PRMSX (30 years) vs RNWFX (23 years). PRMSX is a more actively managed with annual turnover of: 47.60 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than PRMSX: RNWFX (250) vs PRMSX (2500). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. PRMSX (3.84). RNWFX return over 5 years is better than : 17.17 vs. PRMSX (-19.55).
PRMSXRNWFXPRMSX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years23 years-
Gain YTD-0.2897.099-4%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.02B60.9B8%
Annual Yield % from dividends1.091.5173%
Returns for 1 year3.8411.5433%
Returns for 3 years-32.54-14.55224%
Returns for 5 years-19.5517.17-114%
Returns for 10 years6.9741.0017%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics